Trump hint sends Kevin Hassett Fed chair odds soaring in markets
Trump hasn’t confirmed who he will have replace Fed Chair Jerome Powell with next year, but two recent hints, taken together, point to his crypto-friendly adviser.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
Trump hasn’t confirmed who he will have replace Fed Chair Jerome Powell with next year, but two recent hints, taken together, point to his crypto-friendly adviser.
Why this matters
This cryptocurrency story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on CointelegraphRelated market context
New Fed Chair Kevin Warsh holds rates steady, signals hawkish path that could rattle crypto markets
Warsh's hawkish stance and reduced forward guidance could heighten market volatility, particularly impacting sensitive crypto asse...
New Fed Chair Kevin Warsh signals a return to monetarism, and crypto markets should pay attention
Warsh's monetarist approach could tighten liquidity, impacting crypto markets and potentially leading to more volatile economic co...
SEC Chair Backs CLARITY Act — Says He’s ‘Optimistic’ Congress Will Pass Landmark Crypto Bill
SEC Chair Paul Atkins says he is optimistic Congress will pass the CLARITY Act, a landmark crypto market structure bill designed t...
Kevin Warsh’s no-guidance Fed breaks a 30-year playbook – leaving Bitcoin vulnerable to surprise rate hike
Bitcoin fell over the past 24 hours as traders positioned for a Federal Reserve decision that could break a market pattern dating...
SEC Chairman Says He’s ‘Committed’ to Helping Advance Crypto Clarity Act
Bitcoin Magazine SEC Chairman Says He’s ‘Committed’ to Helping Advance Crypto Clarity Act Securities and Exchange Commission Chair...
BNB treasury company dumps its crypto manager after Nasdaq suspends its stock, leaving no one in charge of its treasury
BNB Plus, formerly known as Applied DNA Sciences, now pairs a BNB treasury strategy with its LineaRx biotechnology business. The c...